Register entry
CSL Limited
- Registered sites
- 5
- Drug products
- 1
- Live patents
- 0
- Countries
- 4
- Base
- Switzerland
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Finished drug manufacture
Sites
Facilities
5| Site | Location | Operations | FEI |
|---|---|---|---|
| CSL Behring (Australia) Pty Ltd | BroadmeadowsAustralia | Finished drug manufacture | 3001644620 |
| CSL Behring AG | BernSwitzerland | Finished drug manufacture | 3002806716 |
| CSL Behring Lengnau AG | LengnauSwitzerland | Finished drug manufacture | 3021666267 |
| CSL Behring GmbH | MarburgGermany | Finished drug manufacture | 3003098680 |
| CSL Behring L.L.C. | Bradley, ILUnited States | Finished drug manufacture | 1410248 |
Catalogue
Marketed products
1Showing 1 of 1.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| ANDEMBRY | Garadacimab | INJECTION, SOLUTION | BLA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.